ArticleThe Journal of experimental medicine2005

Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.

Niklas Beyersdorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.